GAMMA Investing’s Aardvark Therapeutics AARD Stock Holding History

GAMMA Investing’s Portfolio AARD Stock Details AARD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.04K	Hold	388	–	–	﹤0.01%	3949
2026 Q2	$2.23K	Buy	+388	New	+$1.81K	﹤0.01%	3712

Other funds holding AARD

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's AARD Position: Q3 2026 in Review

GAMMA Investing held its Aardvark Therapeutics (AARD) position steady in Q3 2026 at 388 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3949.

GAMMA Investing first reported a position in AARD in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.23K in Q2 2026. 2 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

GAMMA Investing held 388 shares of Aardvark Therapeutics worth $2.04K as of Q3 2026.
GAMMA Investing left its Aardvark Therapeutics share count unchanged in Q3 2026.
Aardvark Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3949 holding.
GAMMA Investing first reported a position in Aardvark Therapeutics in Q2 2026 and has held it in 2 quarters since.
GAMMA Investing's Aardvark Therapeutics position peaked at $2.23K in Q2 2026.
2 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.